Autopsy report · NCT02152566

Nasal High Flow Therapy for the Treatment of Respiratory Insufficiencies During Sleep

“Difficulty with recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 4 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Fisher and Paykel Healthcare

Sponsor type

Industry

Conditions

Sleep Disordered Breathing; Congestive Heart Failure

Interventions

Nasal High flow therapy device

Participants

6

Sites

2

Countries

New Zealand

Trials that died the same way

• Morphine in Moderate Obstructive Sleep Apnoea
  “Difficulties with recruitment” (98% match in meaning)
• Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
  “Difficulty in recruitment” (97% match in meaning)
• Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
  “Problems with recruitment” (96% match in meaning)
• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (95% match in meaning)
• Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction
  “recruitment difficulty” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.